# A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

> **NCT00920374** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 118 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluarix™/Influsplit SSW®

## Key facts

- **NCT ID:** NCT00920374
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-16
- **Primary completion:** 2009-07-08
- **Final completion:** 2009-07-08
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00920374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00920374, "A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00920374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*